Kim BS - Search Results

1

Activation of NKT Cells in an Anti-PD-1-Resistant Tumor Model Enhances Antitumor Immunity by Reinvigorating Exhausted CD8 T Cells.

Bae EA, Seo H, Kim BS, Choi J, Jeon I, Shin KS, Koh CH, Song B, Kim IK, Min BS, Han YD, Shin SJ, Kang CY. Bae EA, et al. Among authors: kim bs, kim ik. Cancer Res. 2018 Sep 15;78(18):5315-5326. doi: 10.1158/0008-5472.CAN-18-0734. Epub 2018 Jul 16. Cancer Res. 2018. PMID: 30012672

2

CD1d-restricted T cells license B cells to generate long-lasting cytotoxic antitumor immunity in vivo.

Chung Y, Kim BS, Kim YJ, Ko HJ, Ko SY, Kim DH, Kang CY. Chung Y, et al. Among authors: kim bs, kim yj, kim dh. Cancer Res. 2006 Jul 1;66(13):6843-50. doi: 10.1158/0008-5472.CAN-06-0889. Cancer Res. 2006. PMID: 16818662

3

Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens.

Chung Y, Chang JH, Kim BS, Lee JM, Kim HY, Kang CY. Chung Y, et al. Among authors: kim bs, kim hy. Eur J Immunol. 2007 Jun;37(6):1453-62. doi: 10.1002/eji.200636544. Eur J Immunol. 2007. PMID: 17474148 Free article.

4

Conversion of Th2 memory cells into Foxp3+ regulatory T cells suppressing Th2-mediated allergic asthma.

Kim BS, Kim IK, Park YJ, Kim YS, Kim YJ, Chang WS, Lee YS, Kweon MN, Chung Y, Kang CY. Kim BS, et al. Among authors: kim yj, kim ik, kim ys. Proc Natl Acad Sci U S A. 2010 May 11;107(19):8742-7. doi: 10.1073/pnas.0911756107. Epub 2010 Apr 26. Proc Natl Acad Sci U S A. 2010. PMID: 20421479 Free PMC article.

5

Glucocorticoid-induced tumor necrosis factor receptor-related protein co-stimulation facilitates tumor regression by inducing IL-9-producing helper T cells.

Kim IK, Kim BS, Koh CH, Seok JW, Park JS, Shin KS, Bae EA, Lee GE, Jeon H, Cho J, Jung Y, Han D, Kwon BS, Lee HY, Chung Y, Kang CY. Kim IK, et al. Among authors: kim bs. Nat Med. 2015 Sep;21(9):1010-7. doi: 10.1038/nm.3922. Epub 2015 Aug 17. Nat Med. 2015. PMID: 26280119

6

IL-21-mediated reversal of NK cell exhaustion facilitates anti-tumour immunity in MHC class I-deficient tumours.

Seo H, Jeon I, Kim BS, Park M, Bae EA, Song B, Koh CH, Shin KS, Kim IK, Choi K, Oh T, Min J, Min BS, Han YD, Kang SJ, Shin SJ, Chung Y, Kang CY. Seo H, et al. Among authors: kim bs, kim ik. Nat Commun. 2017 Jun 6;8:15776. doi: 10.1038/ncomms15776. Nat Commun. 2017. PMID: 28585539 Free PMC article.

7

Inhibition of the B7-H3 immune checkpoint limits tumor growth by enhancing cytotoxic lymphocyte function.

Lee YH, Martin-Orozco N, Zheng P, Li J, Zhang P, Tan H, Park HJ, Jeong M, Chang SH, Kim BS, Xiong W, Zang W, Guo L, Liu Y, Dong ZJ, Overwijk WW, Hwu P, Yi Q, Kwak L, Yang Z, Mak TW, Li W, Radvanyi LG, Ni L, Liu D, Dong C. Lee YH, et al. Among authors: kim bs. Cell Res. 2017 Aug;27(8):1034-1045. doi: 10.1038/cr.2017.90. Epub 2017 Jul 7. Cell Res. 2017. PMID: 28685773 Free PMC article.

8

Fibrinogen cleavage products and Toll-like receptor 4 promote the generation of programmed cell death 1 ligand 2-positive dendritic cells in allergic asthma.

Cho M, Lee JE, Lim H, Shin HW, Khalmuratova R, Choi G, Kim HS, Choi WS, Park YJ, Shim I, Kim BS, Kang CY, Kim JO, Tanaka S, Kubo M, Tung HY, Landers CT, Corry DB, Kheradmand F, Chung Y. Cho M, et al. Among authors: kim bs, kim jo, kim hs. J Allergy Clin Immunol. 2018 Aug;142(2):530-541.e6. doi: 10.1016/j.jaci.2017.09.019. Epub 2017 Oct 14. J Allergy Clin Immunol. 2018. PMID: 29038008

9

IL21 Therapy Combined with PD-1 and Tim-3 Blockade Provides Enhanced NK Cell Antitumor Activity against MHC Class I-Deficient Tumors.

Seo H, Kim BS, Bae EA, Min BS, Han YD, Shin SJ, Kang CY. Seo H, et al. Among authors: kim bs. Cancer Immunol Res. 2018 Jun;6(6):685-695. doi: 10.1158/2326-6066.CIR-17-0708. Epub 2018 Apr 3. Cancer Immunol Res. 2018. PMID: 29615398

10

GM-CSF Promotes Antitumor Immunity by Inducing Th9 Cell Responses.

Kim IK, Koh CH, Jeon I, Shin KS, Kang TS, Bae EA, Seo H, Ko HJ, Kim BS, Chung Y, Kang CY. Kim IK, et al. Among authors: kim bs. Cancer Immunol Res. 2019 Mar;7(3):498-509. doi: 10.1158/2326-6066.CIR-18-0518. Epub 2019 Feb 6. Cancer Immunol Res. 2019. PMID: 30728152

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,620 results

Search Page